Standard Biotools Inc (LAB) Stock Price, Quote & News

Company Profile

Standard BioTools Inc., together with its subsidiaries, develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific. The company operates through Proteomics and Genomics segments. Its proteomics and genomics include instruments, consumables, and assays for clinical and diagnostic uses. The company also provides SomaScan platform that...

Industry: Medical Devices

Sector: Healthcare

Phone: 650 266 6000

Fax: 650 871 7152

Website: www.standardbio.com

Address:

50 Milk Street, 10th Floor, Boston, United States

Gunnar1 Apr. 26 at 1:28 PM

$MNKD $NOMD $CALC $LAB $BCRX Greetings from the river Rhine, bicycle tour with my wife in the sun. Have a blessed sunday!

3 · Reply

MoneyTree82 Apr. 24 at 7:27 PM

$LAB Wow! The manipulation 🤦‍♂️ Can’t wait until this is massively manipulated up instead of down!

0 · Reply

OriginalTradeonrumor Apr. 24 at 6:56 PM

$LAB as I mentioned …. .92 is next barrier ….where after that it clears up pretty quickly to .97/.98—-not sure if we’ll do it today or next week but we’ll know in an hour …as long as we finish above .86 it’s all healthy consolidation 👍

0 · Reply

lousyknees Apr. 24 at 3:46 PM

$LAB At this point, it's just embarrassing.

0 · Reply

amda Apr. 24 at 2:55 PM

$LAB how much cash does this company have in its coffers?

0 · Reply

amda Apr. 24 at 2:30 PM

$LAB .98+ target.....

0 · Reply

amda Apr. 24 at 2:07 PM

$LAB loading the boat under .90 - it's been a good trading entry point lately

0 · Reply

OriginalTradeonrumor Apr. 24 at 12:46 PM

$LAB .92 close or at least a hold above .86 is what’s on the menu today—-let’s see what happens!

0 · Reply

OriginalTradeonrumor Apr. 23 at 8:06 PM

$LAB don’t buy yet…look like that $1+ was a bull trap ……but with that says real accumulation ….don’t buy until we close over .92…looks like we are range bound until then…next week or week after the latest we should make another $1 run Let’s see what happens!

0 · Reply

amda Apr. 23 at 7:19 PM

$LAB man, it's time to buy the sh*t out of this thang!

0 · Reply

Standard BioTools Reports Fourth Quarter and Full Year 2025 Financial Results

Feb 10, 2026, 7:00 AM EST - 2 months ago

Standard BioTools to Announce Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026

Jan 30, 2026, 9:09 AM EST - 3 months ago

Standard BioTools Completes Sale of SomaLogic to Illumina

Jan 8, 2026, 7:00 AM EST - 3 months ago

Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2025 Revenue

Nov 19, 2025, 11:30 AM EST - 5 months ago

Molecular Instruments and Standard BioTools Announce Collaboration to Bring Amplified Multi-Omic Readouts to Imaging Mass Cytometry

Nov 10, 2025, 12:15 PM EST - 5 months ago

Illumina® Protein Prep delivers groundbreaking precision in NGS proteomics for more than 40 customers, ranging from academic institutions to large national biobanks

ILMN

Nov 4, 2025, 4:05 PM EST - 6 months ago

Standard BioTools Reports Third Quarter 2025 Financial Results

Oct 21, 2025, 7:00 AM EDT - 6 months ago

Standard BioTools to Announce Third Quarter Financial Results on November 4, 2025

Sep 3, 2025, 9:15 AM EDT - 8 months ago

Illumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development

ILMN

Aug 11, 2025, 4:01 PM EDT - 9 months ago

Standard BioTools Reports Second Quarter 2025 Financial Results

Aug 6, 2025, 7:00 AM EDT - 9 months ago

Standard BioTools and Precision Health Research, Singapore (PRECISE-SG100K) Launch Proteomics Collaboration, Selecting SomaScan to Power Large-Scale Population Health Study

Jul 21, 2025, 7:00 AM EDT - 9 months ago

Standard BioTools Schedules Second Quarter Earnings Conference Call on August 11, 2025

Jun 23, 2025, 7:13 AM EDT - 10 months ago

Illumina to acquire SomaLogic, accelerating its proteomics business and advancing the company's multiomics strategy

ILMN

Jun 23, 2025, 7:05 AM EDT - 10 months ago

Standard BioTools Enters Next Phase of Transformation with Strategic Sale of SomaLogic to Illumina

May 30, 2025, 7:00 AM EDT - 11 months ago

Standard BioTools to Host Inaugural “Proteomics Roundtable” Webcast Series

May 6, 2025, 4:30 PM EDT - 1 year ago

Standard BioTools Earnings Call Transcript: Q1 2025

May 6, 2025, 4:01 PM EDT - 1 year ago

Standard BioTools Reports First Quarter 2025 Financial Results

Apr 24, 2025, 7:00 AM EDT - 1 year ago

Standard BioTools Announces New Product Innovations in Plasma and Single-Cell Proteomics at AACR 2025

Apr 22, 2025, 7:00 AM EDT - 1 year ago

Standard BioTools Schedules First Quarter Earnings Conference Call on May 6, 2025

Mar 19, 2025, 4:30 PM EDT - 1 year ago

Standard BioTools Transcript: KeyBanc Annual Health Care Forum 2025

Mar 3, 2025, 3:10 PM EST - 1 year ago

Standard BioTools Transcript: TD Cowen 45th Annual Healthcare Conference

Feb 27, 2025, 4:01 PM EST - 1 year ago

Standard BioTools to Participate in Upcoming Investor Conferences

Feb 26, 2025, 4:30 PM EST - 1 year ago

Standard BioTools Earnings Call Transcript: Q4 2024

Feb 26, 2025, 4:01 PM EST - 1 year ago

Standard BioTools Reports Fourth Quarter and Full Year 2024 Financial Results

Feb 12, 2025, 7:00 AM EST - 1 year ago

Standard BioTools Schedules Fourth Quarter and Full Year 2024 Earnings Conference Call on February 26, 2025

Jan 16, 2025, 12:45 PM EST - 1 year ago

Standard BioTools Transcript: 43rd Annual J.P. Morgan Healthcare Conference 2025

Jan 13, 2025, 7:00 AM EST - 1 year ago

Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2024 Revenue

Dec 19, 2024, 8:00 AM EST - 1 year ago

Standard BioTools to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Nov 19, 2024, 3:30 AM EST - 1 year ago

Standard BioTools Transcript: Jefferies London Healthcare Conference 2024

Nov 12, 2024, 4:15 PM EST - 1 year ago

Standard BioTools Transcript: UBS Global Healthcare Conference 2024

Nov 7, 2024, 8:00 AM EST - 1 year ago

Standard BioTools Appoints Alex Kim as Chief Financial Officer

Oct 30, 2024, 4:30 PM EDT - 1 year ago

Standard BioTools Earnings Call Transcript: Q3 2024

Oct 30, 2024, 4:01 PM EDT - 1 year ago

Standard BioTools Reports Third Quarter 2024 Financial Results

Oct 16, 2024, 8:00 AM EDT - 1 year ago

Standard BioTools Announces Conference Call and Webcast for Third Quarter 2024 Financial Results on October 30, 2024

Sep 6, 2024, 8:30 AM EDT - 1 year ago

Standard BioTools Transcript: Morgan Stanley 22nd Annual Global Healthcare Conference

Aug 28, 2024, 8:58 AM EDT - 1 year ago

Standard BioTools And 2 Other Penny Stocks Executives Are Buying

Aug 27, 2024, 9:15 AM EDT - 1 year ago

Standard BioTools And 3 Other Stocks Under $3 Executives Are Buying

Aug 14, 2024, 5:00 PM EDT - 1 year ago

Standard BioTools Transcript: UBS Genomic Medicine Summit

Aug 13, 2024, 9:00 AM EDT - 1 year ago

Standard BioTools Transcript: Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 2024

Jul 31, 2024, 4:30 PM EDT - 1 year ago

Standard BioTools Earnings Call Transcript: Q2 2024

Jul 31, 2024, 4:02 PM EDT - 1 year ago

Standard BioTools Announces Senior Leadership Changes

Jul 31, 2024, 4:01 PM EDT - 1 year ago

Standard BioTools Reports Second Quarter 2024 Financial Results

Jul 17, 2024, 8:01 AM EDT - 1 year ago

Standard BioTools Announces Conference Call and Webcast for Second Quarter 2024 Financial Results on July 31, 2024

Jun 5, 2024, 2:30 PM EDT - 2 years ago

Standard BioTools Transcript: Jefferies Global Healthcare Conference

May 28, 2024, 4:01 PM EDT - 2 years ago

Standard BioTools Purchases the Carterra® LSA-XT System to Accelerate Data Delivery and Provide Greater Validation to SomaScan Customers

May 20, 2024, 8:00 AM EDT - 2 years ago

Standard BioTools Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

May 8, 2024, 4:30 PM EDT - 2 years ago

Standard BioTools Earnings Call Transcript: Q1 2024

May 8, 2024, 4:01 PM EDT - 2 years ago

Standard BioTools Reports First Quarter 2024 Financial Results

Apr 25, 2024, 8:01 AM EDT - 2 years ago

Standard BioTools Announces Operational Restructuring Plan to Drive Long-Term Profitable Growth

Apr 8, 2024, 8:00 AM EDT - 2 years ago

Standard BioTools Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the boundaries of Tissue Imaging

Apr 3, 2024, 4:01 PM EDT - 2 years ago

Standard BioTools Announces Multi-Year Strategic Engagement with Bristol Myers Squibb for Use of the SomaScan® Platform for Translational Medicine Research

Mar 19, 2024, 10:30 AM EDT - 2 years ago

Standard BioTools Transcript: KeyBanc Capital Markets Life Sciences & MedTech Investor Forum

Mar 18, 2024, 8:12 AM EDT - 2 years ago

Standard BioTools Announces Exchange of All Outstanding Series B Convertible Preferred Stock for Common Stock

Mar 6, 2024, 1:30 PM EST - 2 years ago

Standard BioTools Transcript: TD Cowen 44th Annual Health Care Conference 2024

Feb 28, 2024, 4:30 PM EST - 2 years ago

Standard BioTools Earnings Call Transcript: Q4 2023

Feb 28, 2024, 4:01 PM EST - 2 years ago

Standard BioTools Reports Fourth Quarter and Full Year 2023 Financial Results

Feb 14, 2024, 8:30 AM EST - 2 years ago

Standard BioTools Announces Conference Call and Webcast for Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024

Feb 7, 2024, 8:30 AM EST - 2 years ago

Standard BioTools and Navignostics Announce Collaboration Agreement to Advance Imaging Capabilities in Personalized Medicine

Jan 8, 2024, 8:30 AM EST - 2 years ago

Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2023 Revenue

Jan 5, 2024, 8:46 AM EST - 2 years ago

Standard BioTools Completes Merger with SomaLogic, Creating a Diversified and Scaled Leader in Life Sciences Tools

Jan 4, 2024, 10:23 PM EST - 2 years ago

Standard BioTools Stockholders Approve Merger with SomaLogic

Jan 4, 2024, 9:44 PM EST - 2 years ago

SomaLogic Stockholders Vote to Approve Standard BioTools Transaction at Special Meeting

Dec 31, 2023, 2:10 PM EST - 2 years ago

Boston Millennia Partners Intends to Vote Against Proposed Merger of SomaLogic With Standard BioTools

Dec 29, 2023, 7:10 PM EST - 2 years ago

Madryn Asset Management Highlights Increasing Public Shareholder Opposition to Value-Destructive SomaLogic Merger and Calls on Company to Make Additional Disclosures

Dec 29, 2023, 5:04 PM EST - 2 years ago

Glass Lewis Recommends Standard BioTools Stockholders Vote “FOR” All Proposals Relating to Proposed Merger with SomaLogic

Dec 28, 2023, 4:16 PM EST - 2 years ago

Dr. Larry Gold and Dr. Jason Cleveland Issue Open Letter to SomaLogic Stockholders Opposing SomaLogic's Proposed Merger with Standard BioTools

Dec 22, 2023, 8:11 PM EST - 2 years ago

Tikvah Management Announces Intention to Vote against Somalogic's Proposed Merger with Standard BioTools

Nov 15, 2023, 6:00 AM EST - 2 years ago

Standard BioTools Transcript: 14th Annual Jefferies London Healthcare Conference 2023

Nov 7, 2023, 4:30 PM EST - 2 years ago

Standard BioTools Earnings Call Transcript: Q3 2023

Oct 4, 2023, 8:30 AM EDT - 2 years ago

Standard BioTools Transcript: Business Combination

Aug 16, 2023, 10:00 AM EDT - 2 years ago

Standard BioTools Transcript: UBS MedTech, Tools and Genomics Summit

Aug 8, 2023, 5:00 PM EDT - 2 years ago

Standard BioTools Earnings Call Transcript: Q2 2023

May 9, 2023, 5:00 PM EDT - 3 years ago

Standard BioTools Earnings Call Transcript: Q1 2023

Feb 14, 2023, 5:00 PM EST - 3 years ago

Standard BioTools Earnings Call Transcript: Q4 2022

Nov 8, 2022, 7:00 AM EST - 3 years ago

Standard BioTools Earnings Call Transcript: Q3 2022

Aug 8, 2022, 4:30 PM EDT - 4 years ago

Standard BioTools Earnings Call Transcript: Q2 2022

Gunnar1 Apr. 26 at 1:28 PM

$MNKD $NOMD $CALC $LAB $BCRX Greetings from the river Rhine, bicycle tour with my wife in the sun. Have a blessed sunday!

3 · Reply

MoneyTree82 Apr. 24 at 7:27 PM

$LAB Wow! The manipulation 🤦‍♂️ Can’t wait until this is massively manipulated up instead of down!

0 · Reply

OriginalTradeonrumor Apr. 24 at 6:56 PM

0 · Reply

lousyknees Apr. 24 at 3:46 PM

$LAB At this point, it's just embarrassing.

0 · Reply

amda Apr. 24 at 2:55 PM

$LAB how much cash does this company have in its coffers?

0 · Reply

amda Apr. 24 at 2:30 PM

$LAB .98+ target.....

0 · Reply

amda Apr. 24 at 2:07 PM

$LAB loading the boat under .90 - it's been a good trading entry point lately

0 · Reply

OriginalTradeonrumor Apr. 24 at 12:46 PM

$LAB .92 close or at least a hold above .86 is what’s on the menu today—-let’s see what happens!

0 · Reply

OriginalTradeonrumor Apr. 23 at 8:06 PM

0 · Reply

amda Apr. 23 at 7:19 PM

$LAB man, it's time to buy the sh*t out of this thang!

0 · Reply

OriginalTradeonrumor Apr. 23 at 5:42 PM

$LAB getting flushed right now …looking to see if tutes step in with a strong green candle to get us to .91+—- if not then .90 is our resistance Let’s see what happens!

0 · Reply

MoneyTree82 Apr. 23 at 5:37 PM

$LAB dip and then rip???? Look at the market cap! This isn’t even the cash on hand!!! Start buying up cheap shares! $VOO

0 · Reply

MoneyTree82 Apr. 23 at 2:53 PM

$LAB December 2025 this was $1.60 now we are 90 cents. What had structurally changed This should still be $1.50 or more $NDAQ $XBI

0 · Reply

MoneyTree82 Apr. 23 at 1:38 PM

$LAB well I miss the over $1 from two days ago! Hopefully when the big money wakes up we get some big buys again at these discounted levels Happy trading!

0 · Reply

OriginalTradeonrumor Apr. 21 at 4:00 PM

$LAB there will be several rounds to overcome $1…but it’s clear we are nearing the time where we conquer!!!

0 · Reply

OkieDokieTrader Apr. 21 at 3:46 PM

$LAB Juicy!!!! $1 Strike!!

0 · Reply

OriginalTradeonrumor Apr. 21 at 1:59 PM

$LAB the battle begins!

0 · Reply

OriginalTradeonrumor Apr. 21 at 1:48 PM

$LAB first attack on $1 today! Let’s see what happens!

0 · Reply

StocksGoddess Apr. 21 at 3:00 AM

$ARAY $LAB

0 · Reply

johnny111 Apr. 20 at 4:05 PM

$LAB This could be a great buy. 1.70 in Jan. insider buying, 459mil, cash 350mil Market cap, Royalties from illumina from the somalogic sale.

0 · Reply

johnny111 Apr. 20 at 3:37 PM

$LAB the may 1 calls are only .05

0 · Reply

johnny111 Apr. 20 at 3:35 PM

$LAB the options are only .05 for may 1

1 · Reply

Market Cap	350.87M
Revenue (ttm)	85.33M
Net Income (ttm)	-74.90M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-87.78%
Debt to Equity Ratio	0.00

Volume	1,593,400
Avg Vol	2,598,264
Day's Range	N/A - N/A
Shares Out	390.07M
Stochastic %K	17%
Beta	1.42
Analysts	Sell
Price Target	$1.55